Trial Profile
Study of elbasvir/grazoprevir for Japanese patients with genotype 1b chronic hepatitis C
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Aug 2018
Price :
$35
*
At a glance
- Drugs Elbasvir/grazoprevir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 31 Aug 2018 New trial record
- 25 Aug 2018 Results published in the Journal of Gastroenterology and Hepatology